Reitan Colleen F

Reitan Colleen F is listed in filings as Director at Myriad Genetics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Myriad Genetics, Inc. (MYGN) and Alnylam Pharmaceuticals Inc (ALNY). The current snapshot covers public activity from Sep 4, 2024 to Jun 5, 2026. Reported amounts are shown as $430.1K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.